Biosynthesis of N-acetylaspartate

N-乙酰天冬氨酸的生物合成

• 批准号: 6867819
• 负责人: ARYAN Mangalam NAMBOODIRI
• 金额: $ 16.94万
• 依托单位: HENRY M. JACKSON FDN FOR THE ADV MIL/MED
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-30 至 2006-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6867819
• 关键词: acyltransferase; affinity chromatography; aminoacid biosynthesis; aspartate; enzyme complex; glutamates; hybridomas; immunocytochemistry; immunologic substance development /preparation; laboratory mouse; laboratory rat; mitochondria; monoclonal antibody; neural degeneration; neurochemistry; neurons; oxidation; perfusion; protein localization; protein purification; schizophrenia

DESCRIPTION (provided by applicant): N-Acetylaspartate (NAA) is an abundant (5-10 mM) amino acid derivative of the nervous system, which is used clinically as a noninvasive marker for the functional integrity of neurons using magnetic resonance spectroscopy. Decreased degradation of NAA resulting from a congenital defect in the degradative enzyme aspartoacylase causes Canavan disease, an autosomal-recessive neurodegenerative disorder that develops after birth and results in death before 10 years of age. Other studies have shown decreases in NAA in specific neuronal systems in a number of neurological disorders, including schizophrenia. Importance of NAA in neuronal functions has been further emphasized by recent reports that show a strong association between NAA and cognitive ability and intelligence in humans. The long-term goal of this proposal is to determine the specific roles of NAA in neuronal functions. The central hypothesis is that NAA is an integral component of the glutamate oxidation system in neuronal mitochondria. The immediate objectives are to 1) purify the biosynthetic enzyme aspartate N-acetyltransferase from rat brain mitochondria and 2) generate antibodies against the enzyme and determine its cellular localization by immunohistochemistry. Toward these objectives, we have partially purified the enzyme from rat brain mitochondria and characterized it as a high molecular weight enzyme complex. The proposed studies would set the foundation for subsequent studies to test whether or not NAA mediates one or more neuronal functions, instead of serving merely as a marker for the functional integrity of neurons. Such studies should help to determine whether or not the decreases in NAA observed in neurological diseases, such as schizophrenia, play a role in their pathogenesis. Based on the above information, biochemical approaches aimed at replenishing the NAA could be developed as a novel therapeutic strategy.

描述（由申请人提供）：n -乙酰天冬氨酸（NAA）是神经系统中丰富的（5-10 mM）氨基酸衍生物，临床使用磁共振波谱法作为神经元功能完整性的无创标志物。先天性降解酶天冬氨酸酰化酶缺陷导致NAA降解减少，导致Canavan病，这是一种常染色体隐性神经退行性疾病，在出生后发展，导致10岁前死亡。其他研究表明，在包括精神分裂症在内的许多神经系统疾病中，特定神经系统中的NAA减少。最近的报道进一步强调了NAA在神经元功能中的重要性，这些报道显示了NAA与人类认知能力和智力之间的密切联系。这项提议的长期目标是确定NAA在神经元功能中的具体作用。核心假设是NAA是神经元线粒体中谷氨酸氧化系统的一个组成部分。目前的目标是：1)从大鼠脑线粒体中纯化生物合成酶天冬氨酸n -乙酰转移酶，2)产生针对该酶的抗体，并通过免疫组织化学确定其细胞定位。为此，我们从大鼠脑线粒体中部分纯化了该酶，并将其定性为高分子量酶复合物。提出的研究将为后续研究奠定基础，以测试NAA是否介导一种或多种神经元功能，而不仅仅是作为神经元功能完整性的标志。这些研究应该有助于确定在精神分裂症等神经疾病中观察到的NAA减少是否在其发病机制中起作用。基于上述信息，旨在补充NAA的生化方法可以作为一种新的治疗策略。